Imodium

Loperamide, the active ingredient in Imodium, is a peripheral opioid receptor agonist presented as an oral tablet for oral use. It reduces intestinal motility and is used to manage acute, travel‑related, and chronic diarrhea in adults and children.

GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium (loperamide) acts on the gastrointestinal tract to control excess stool output in several diarrheal conditions.

Acute nonspecific diarrhea: provides rapid reduction of stool frequency and improves consistency. Traveler's diarrhea: helps travelers regain normal bowel function while away from home. Chronic diarrhea: assists in long‑term management of persistent diarrheal disorders such as those associated with inflammatory bowel disease.

Loperamide is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Constipation: reduced bowel movements beyond therapeutic intent. - Abdominal cramps: mild to moderate discomfort. - Nausea: occasional feeling of queasiness. - Dry mouth: reduced salivation. - Dizziness: transient light‑headedness. - Fatigue: mild tiredness.

Serious or Rare Side Effects: - Severe constipation leading to bowel obstruction. - Toxic megacolon in patients with underlying inflammatory bowel disease. - Cardiac arrhythmias: QT prolongation or ventricular tachycardia. - Allergic reactions: rash, itching, or swelling. - Hepatotoxicity: elevated liver enzymes in rare cases. - Central nervous system depression: excessive sedation or respiratory depression (rare).

Before using Imodium, consider the following safety measures. - Contraindication: avoid in patients with known hypersensitivity to loperamide. - Caution: do not use in cases of bacterial dysentery or colitis without physician guidance. - Monitoring: assess for signs of worsening constipation or abdominal distension. - Pregnancy: discuss potential risks with a healthcare professional before use. - Breastfeeding: consult a physician as loperamide may be excreted in milk. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Loperamide may interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of cardiac toxicity. - P-glycoprotein inhibitors (e.g., quinidine, verapamil): can raise systemic exposure, heightening adverse effects.

Moderate Interactions (Monitor Closely): - Opioid analgesics: additive central opioid effects may increase sedation. - Anticholinergic agents: may exacerbate constipation. - Antidiarrheal combination products: risk of excessive slowing of gut motility. - Antifungal azoles (e.g., itraconazole): may modestly raise loperamide concentrations.